Rafferty Asset Management, LLC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1389426 New York, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$707,094

-$311,665 QoQ

Shares Held

18,075

-52.0% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#76

of 156 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. RIGL ranks #104 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$707,094	18,075	-52.0%	Shares	Sole	2026-08-14
2026-03-31	$1,018,759	37,676	-12.6%	Shares	Sole	2026-05-15
2025-12-31	$1,845,930	43,099	+215.1%	Shares	Sole	2026-02-13
2025-09-30	$387,497	13,678	-25.2%	Shares	Sole	2025-11-12
2025-06-30	$342,721	18,298	-14.5%	Shares	Sole	2025-08-14
2025-03-31	$384,932	21,397	-98.0%	Shares	Sole	2025-05-14
2022-06-30	$1,230,053	1,088,543	+212.6%	Shares	Sole	2022-08-12
2022-03-31	$1,041,201	348,228	-28.4%	Shares	Sole	2022-05-13
2021-12-31	$1,288,671	486,291	+64.6%	Shares	Sole	2022-02-10
2021-09-30	$1,072,650	295,496	-28.3%	Shares	Sole	2021-11-10
2021-06-30	$1,788,409	412,076	-34.1%	Shares	Sole	2021-08-10
2021-03-31	$2,138,977	625,432	+602.3%	Shares	Sole	2021-05-10
2020-12-31	$311,710	89,060	-67.1%	Shares	Sole	2021-02-10
2020-09-30	$649,761	270,734	—	Shares	Sole	2020-11-13
No filing history on record for this holder in this stock.